Azerbaijan vs Mus: Estimated antiretroviral therapy coverage among children
Azerbaijan
87
in 2025
Mus
98
in 2025
Azerbaijan rank
3rd
Mus rank
1st
Estimated antiretroviral therapy coverage among children over time
- Azerbaijan
- Mus
How they compare
Mus currently reports 98 against 87 in Azerbaijan, a difference of 11.
That makes Mus's figure about 1.1 times Azerbaijan's.
The two have swapped places 4 times across 26 shared years of data; in 2000 it was Mus ahead.
Azerbaijan ranks 3rd and Mus ranks 1st of 89 countries.
Mus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.2 | 8.8 | 8.6 | Mus |
| 2010s | 34.2 | 41.8 | 7.6 | Mus |
| 2020s | 72.67 | 95.67 | 23 | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among children, Azerbaijan or Mus?
- Mus, at 98 against 87 in Azerbaijan as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among children between Azerbaijan and Mus?
- 11, with Mus ahead.
- How many years of comparable data are there for Azerbaijan and Mus?
- 26 years are reported by both, from 2000 to 2025.
- How do Azerbaijan and Mus rank globally for estimated antiretroviral therapy coverage among children?
- Azerbaijan ranks 3rd and Mus ranks 1st of 89 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among children. Statizoid refreshes it automatically from the source and publishes the full history for both places.